Ansell Beheer

Beheer criteriumcontroles 3/4

De CEO Ansell is Neil Salmon, benoemd in Sep2021, heeft een ambtstermijn van 3.17 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 1.82M, bestaande uit 44.8% salaris en 55.2% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.088% van de aandelen van het bedrijf, ter waarde A$ 4.22M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 2.3 jaar en 5.1 jaar.

Belangrijke informatie

Neil Salmon

Algemeen directeur

US$1.8m

Totale compensatie

Percentage CEO-salaris	44.8%
Dienstverband CEO	3.2yrs
Eigendom CEO	0.09%
Management gemiddelde ambtstermijn	2.3yrs
Gemiddelde ambtstermijn bestuur	5.1yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Neil Salmon's beloning veranderd ten opzichte van Ansell's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Jun 30 2024	US$2m	US$814k	US$77m
Mar 31 2024	n/a	n/a	US$90m
Dec 31 2023	n/a	n/a	US$104m
Sep 30 2023	n/a	n/a	US$126m
Jun 30 2023	US$1m	US$765k	US$148m
Mar 31 2023	n/a	n/a	US$147m
Dec 31 2022	n/a	n/a	US$145m
Sep 30 2022	n/a	n/a	US$152m
Jun 30 2022	US$2m	US$767k	US$159m
Mar 31 2022	n/a	n/a	US$188m
Dec 31 2021	n/a	n/a	US$218m
Sep 30 2021	n/a	n/a	US$232m
Jun 30 2021	US$4m	US$611k	US$247m
Mar 31 2021	n/a	n/a	US$222m
Dec 31 2020	n/a	n/a	US$197m
Sep 30 2020	n/a	n/a	US$177m
Jun 30 2020	US$3m	US$566k	US$157m
Mar 31 2020	n/a	n/a	US$147m
Dec 31 2019	n/a	n/a	US$138m
Sep 30 2019	n/a	n/a	US$125m
Jun 30 2019	US$2m	US$581k	US$112m
Mar 31 2019	n/a	n/a	US$112m
Dec 31 2018	n/a	n/a	US$112m
Sep 30 2018	n/a	n/a	US$125m
Jun 30 2018	US$2m	US$585k	US$139m

Compensatie versus markt: De totale vergoeding ($USD 1.82M ) Neil } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de Australian markt ($USD 2.20M ).

Compensatie versus inkomsten: De beloning van Neil is het afgelopen jaar met meer dan 20% gestegen, terwijl de winst van het bedrijf met meer dan 20% is gedaald.

CEO

Neil Salmon (55 yo)

3.2yrs

Tenure

US$1,818,429

Compensatie

Mr. Neil I. Salmon, BA, ACMA, serves as the Managing Director & Chief Executive Officer at Ansell Limited since September 1, 2021 and serves as its Director since 2021. He served as the President of Indust...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Neil Salmon	MD, CEO & Director	3.2yrs	US$1.82m	0.088% A$ 4.2m
Zubair Javeed	Chief Financial Officer	5.6yrs	US$1.08m	0.044% A$ 2.1m
Rikard Fröberg	Chief Product & Marketing Officer	1.8yrs	US$957.18k	0.065% A$ 3.1m
John Marsden	Chief Operations & Supply Chain Officer	5.6yrs	geen gegevens	geen gegevens
Deanna Johnston	Chief Information Officer	4.5yrs	geen gegevens	geen gegevens
Michael Evans	Senior Director of Investor Relations and Corporate M&A	2.8yrs	geen gegevens	geen gegevens
Philippe Rommel	General Counsel	less than a year	geen gegevens	geen gegevens
Charlotte Doll	Chief Human Resource Officer	less than a year	geen gegevens	geen gegevens
Francois Le Jeune	Chief Commercial Officer of Guardian Administration	2.8yrs	geen gegevens	geen gegevens
Augusto Accorsi	Chief Commercial Officer of EMEA & APAC	1.8yrs	geen gegevens	geen gegevens
Sean Sweeney	Chief Commercial Officer of Americas	1.8yrs	geen gegevens	geen gegevens
Rob Hughes	Senior VP of Kimtech™ & KleenGuard™ Business Unit	less than a year	geen gegevens	geen gegevens

2.3yrs

Gemiddelde duur

Ervaren management: Het managementteam van ANN wordt beschouwd als ervaren (gemiddelde ambtstermijn 2.3 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Neil Salmon	MD, CEO & Director	3.8yrs	US$1.82m	0.088% A$ 4.2m
Nigel Garrard	Independent Non-Executive Chairman	4.7yrs	US$310.59k	0.012% A$ 562.2k
William Reilly	Independent Non-Executive Director	7.1yrs	US$178.80k	0.036% A$ 1.7m
Christina Stercken	Independent Non-Executive Director	7.1yrs	US$196.80k	0.011% A$ 502.4k
Morten Falkenberg	Independent Non-Executive Director	3yrs	US$178.80k	0.0065% A$ 312.4k
Leslie Desjardins	Independent Non-Executive Director	9yrs	US$196.80k	0.011% A$ 509.5k
Debra Goodin	Independent Non Executive Director	1.9yrs	US$178.80k	0.0014% A$ 64.6k
Christine Yan	Independent Non-Executive Director	5.6yrs	US$191.14k	0.012% A$ 584.6k

5.1yrs

Gemiddelde duur

63.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van ANN wordt beschouwd als ervaren (gemiddelde ambtstermijn 5.1 jaar).

Ansell Beheer

Beheer criteriumcontroles 3/4

Belangrijke informatie

Recente managementupdates

Ansell Limited Announces Zubair Javeed Intention to Resign as Chief Financial Officer

Ansell Limited Announces Board Changes, Effective on 24 October 2023

Ansell Limited Announces Appointment of Debra Goodin as an Independent Nonexecutive Director

Non-Executive Director recently bought AU$130k worth of stock

Ansell Limited, Annual General Meeting, Oct 26, 2023

High number of new directors

Recent updates

Ansell Limited Announces Zubair Javeed Intention to Resign as Chief Financial Officer

Final dividend of US$0.22 announced

Ansell Limited Announces Final Dividend for the Year Ended June 30, 2024 , Payable on September 12, 2024

New minor risk - Profit margin trend

Full year 2024 earnings released: EPS: US$0.59 (vs US$1.17 in FY 2023)

Ansell Limited (ASX:ANN) completed the acquisition of Personal Protective Equipment business of Kimberly-Clark Corporation (NYSE:KMB).

Ansell Limited to Report Fiscal Year 2025 Results on Aug 26, 2025

Ansell Limited has filed a Follow-on Equity Offering in the amount of AUD 400.000001 million.

Ansell Limited has filed a Follow-on Equity Offering in the amount of AUD 400.000001 million.

First half dividend of US$0.17 announced

First half 2024 earnings released: EPS: US$0.15 (vs US$0.51 in 1H 2023)

Ansell Limited Declares Dividend for the Six Months Ended December 31, 2023, Payable on March 14, 2024

Ansell Limited Provides Earnings Guidance for the Year 2024

Ansell Limited Declares Final Dividend for Year Ended 30 June 2023, Payable on 7 September 2023

Full year 2023 earnings released: EPS: US$1.18 (vs US$1.25 in FY 2022)

Investor sentiment deteriorates as stock falls 16%

Ansell Limited Provides Earnings Guidance for the Full Year Ended 30 June 2023 and Fiscal Year 2024

Ansell Limited to Report First Half, 2024 Results on Feb 20, 2024

Ansell Limited to Report First Half, 2024 Results on Feb 20, 2024

Now 21% undervalued after recent price drop

Ansell Limited Announces Board Changes, Effective on 24 October 2023

First half 2023 earnings released: EPS: US$0.51 (vs US$0.61 in 1H 2022)

Now 24% undervalued after recent price drop

Ansell Limited Announces Dividend for the Six Months Ended December 31, 2022, Payable on March 9, 2023

Ansell Limited Announces Appointment of Debra Goodin as an Independent Nonexecutive Director

Non-Executive Director recently bought AU$130k worth of stock

Ansell Limited to Report First Half, 2023 Results on Feb 14, 2023

Full year 2022 earnings released: EPS: US$1.25 (vs US$1.92 in FY 2021)

Ansell Limited, Annual General Meeting, Oct 26, 2023

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Ansell Limited Announces Dividend for the Period of Six Months Ended December 31, 2021, Payable on March 09, 2022

Investor sentiment deteriorated over the past week

Ansell Limited Revises Earnings Guidance for the Fiscal Year 2022

High number of new directors

Ansell Limited Provides Earnings Guidance for the Fiscal Year 2022

Full year 2021 earnings released: EPS US$1.92 (vs US$1.22 in FY 2020)

New 90-day high: AU$39.25

First half 2021 earnings released: EPS US$0.83 (vs US$0.50 in 1H 2020)

Revenue misses expectations

Ansell Limited Revises Financial Guidance for the Fiscal Year 2021

Ansell Limited (ASX:ANN) acquired life science business from Primus Gloves Private Limited and SANREA Healthcare Products Pvt Limited.

Independent Non-Executive Director recently sold AU$260k worth of stock

New 90-day low: AU$35.58

MD, CEO & Executive Director recently sold AU$3.2m worth of stock

New 90-day high: AU$42.03

New 90-day high: AU$41.05

Independent Non-Executive Director recently bought AU$55k worth of stock

Independent Non-Executive Director recently bought AU$55k worth of stock

Full year earnings released - EPS AU$1.22

Ansell Limited to Report Fiscal Year 2021 Results on Aug 24, 2021

New 90-day high - AU$40.57

New 90-day high - AU$39.20

Ansell Limited (ASX:ANN) completed the acquisition 50% stake in CAREPLUS (M) SDN. BHD from Careplus Group Berhad (KLSE:CAREPLS).

Analyse CEO-vergoeding

CEO

Tenure

Compensatie

Leiderschapsteam

Gemiddelde duur

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd